-IPS News TIKAMGARH: Eighty-year-old Chenabai Kushwaha sits on a charpoy under a neem tree in the village of Chitawar, located in the Tikamgarh district in the central Indian state of Madhya Pradesh, staring intently at a dictaphone. “Please sing a song for us,” urges the woman holding the voice recorder. Kushwaha obliges with a melancholy tune about an eight-year-old girl begging her father not to give her away in marriage. The melody melts...
More »SEARCH RESULT
Medical devices like stents, implants set to come under price control -Rupali Mukherjee
-The Times of India MUMBAI: Faced with complaints of overpricing of medical devices like cardiac stents and implants, the government seems to be finally getting its act together. According to a government official, in a string of measures to regulate the industry under the Draft National Medical Device Policy, it has recommended creating an autonomous body — the National Medical Devices Authority (NDMA) — pricing control for medical devices by including them...
More »Govt resurrects Jan Aushadhi, to push generic drugs cheap
-Hindustan Times The government is set to re-launch its pharmacy chain, Jan Aushadhi, to sell generic drugs ranging from anti-biotics, anti-cardiac, anti-infective and gastro intestinal drugs at prices at least half of branded drugs. The project would be launched in six states on a pilot basis from June 21, where 5,000 stores would be opened across the country in a phased manner. The scheme failed in 2008 due to poor supply-chain management. “Now, we...
More »TB, diabetes drug prices to fall by 30% -Sushmi Dey
-The Times of India NEW DELHI: The drug price regulator has capped prices of 30 medicines including antibiotics and those used in treatment of diabetes, tuberculosis and malaria. The move is expected to bring down prices of most of these medicines by 25-30%. However, in some cases the reduction could be by as much as 50%. The National Pharmaceutical Pricing Authority (NPPA), which has the mandate to regulate prices of essential medicines,...
More »Pharma Patents after 10 Years
-Economic and Political Weekly Ten years on, the progressive provisions of the amended Indian Patents Act are being watered down. Ten years have passed since the Indian Patents Act, 1970 was amended in 2005 to bring the country’s laws in line with the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). The most important of the 2005 amendments was the introduction of product patents for 20 years, including for pharmaceutical products,...
More »